Stress-induced phosphoprotein 1 (STIP1) gene expression in adenomyosis: An observational case-control study

Background. Endometriosis is distinguished by its high prevalence and significant impact on the quality of life and reproductive health of women; however, its etiology and essential pathogenesis of remain uncertain so far. Modern research is increasingly focusing on immune, hormonal and genetic factors that share a common structure and participate in common metabolism — so-called single nucleotide polymorphisms (SNPs), including stress-induced phosphoprotein 1 (STIP1), which participates in tissue and cellular metabolism through transcription splicing and folding of RNA. The role of this protein, known as heat shock protein (HSP)-organizing protein, is being actively studied in cancer and hyperproliferative diseases. The role of the STIP1 gene and its product in the pathogenesis of adenomyosis appears to be studied insufficiently, thereby determining the relevance of the present study.

Objectives. To evaluate the expression of stress-induced phosphoprotein 1 in eutopic endometrium and myometrium in women with isolated adenomyosis, as well as in combination with other benign hyperproliferative diseases of the reproductive system.

Methods. Clinical study site: Clinical and Diagnostic Department of Ott Research Institute of Obstetrics, Gynecology and Reproductology. Design: an observational case-control study of patients with verified diagnoses of diffuse adenomyosis, uterine fibroids, and external genital endometriosis (main group — n = 55). The study group (n = 43) was divided into three subgroups: patients with isolated diffuse adenomyosis (AM, n = 16), adenomyosis in combination with uterine fibroids (AM + UF, n = 16), adenomyosis in combination with external genital endometriosis (AM + EGE, n = 11)), a comparison group — patients with uterine fibroids (n = 12) and a control group (n = 17) — women of reproductive age without gynecological diseases. The study was conducted from November 1, 2022 to September 30, 2023. The target indicator of the study was the level of relative mRNA (mRNA) expression of STIP1 gene (in RQ (Relative Quantity) units) in the uterus — adenomyosis glands, surrounding myometrium and endometrium. Histological evaluation of the endometrium served as an additional indicator. Statistical analysis of the results obtained, namely the relative level of mRNA expression, was carried out by the ΔΔСt method using the Expression Suit V1.0.3 program. (https://www.thermofisher.com/ru/ru/home/technical-resources/software-downloads/expressionsuite-software.html). The data analysis was performed using the GraphPad Prizm program (Insight Partners, USA). Differences between groups were evaluated by means of single factor ANOVA analysis (followed by post-hoc pairwise comparisons (Tukey test) of the values in each group. The differences were considered statistically significant at p < 0.05.

Results. A high level of STIP1 gene expression was reported in myometrium of patients with isolated adenomyosis (more than 3-fold increase in relation to the comparison group — patients with uterine fibroids). In addition, myometrium of women with adenomyosis combined with uterine fibroids demonstrated a higher expression of STIP1 gene, compared to patients with isolated uterine fibroids (p < 0.01). The evaluation of the expression of mRNA of the STIP1 gene in the eutopic endometrium of patients with adenomyosis and women in the control group revealed no significant differences; however, STIP1 in the endometrium of women with adenomyosis was significantly lower than in the endometrium of both patients with uterine fibroids and women with adenomyosis combined with external genital endometriosis.

Conclusion. Increased mRNA expression of STIP1 gene in myometrium in adenomyosis confirms its role in the pathogenesis of this disease. The role of the expression of the STIP1 gene and the corresponding protein is to be further clarified in order to assess its specificity and sensitivity as a diagnostic marker and to identify new approaches to the treatment of adenomyosis.

1. Malysheva OV, Yarmolinskaya MI. Genetic determinants of adenomyosis. Obstetrics and Gynecology. 2023;(4):20–27 (In Russ.). https://dx.doi.org/10.18565/aig.2023.52

2. Chen T, Xu Y, Xu X, Wang J, Qiu Z, Yu Y, Jiang X, Shao W, Bai D, Wang M, Mei S, Cheng T, Wu L, Gao S, Che X. Comprehensive transcriptional atlas of human adenomyosis deciphered by the integration of single-cell RNA-sequencing and spatial transcriptomics. Protein Cell. 2024;15(7):530–546. https://doi.org/10.1093/procel/pwae012

3. Adamyan LV, Kuznetsova MV, Pivazyan LG, Davydova YuD, Trofimov DYu. Genetic aspects of endometriosis and adenomyosis: a modern view on the problem. Russian Journal of Human Reproduction. 2023;29(4– 2):14–22 (In Russ.). https://doi.org/10.17116/repro20232904214

4. Chen D, Zhou L, Qiao H, Wang Y, Xiao Y, Fang L, Yang B, Wang Z. Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis. Exp Ther Med. 2022;23(6):374. https://doi.org/10.3892/etm.2022.11301

5. Tsai CL, Lee YS, Chao A, Yen CF, Wang HS, Wang TH. Associations between a single nucleotide polymorphism of stress-induced phosphoprotein 1 and endometriosis/adenomyosis. Taiwan J Obstet Gy‑necol. 2018;57(2):270–275. https://doi.org/10.1016/j.tjog.2018.03.001

6. Baindur-Hudson S, Edkins AL, Blatch GL. Hsp70/Hsp90 organising protein (hop): beyond interactions with chaperones and prion proteins. Subcell Biochem. 2015;78:69–90. https://doi.org/10.1007/978-3-31911731-7_3

7. Wang HS, Tsai CL, Chang PY, Chao A, Wu RC, Chen SH, Wang CJ, Yen CF, Lee YS, Wang TH. Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis. PLoS One. 2018;13(1):e0190573. https://doi.org/10.1371/journal.pone.0190573

8. da Fonseca ACC, Matias D, Geraldo LHM, Leser FS, Pagnoncelli I, Garcia C, et al. The multiple functions of the co-chaperone stress inducible protein 1. Cytokine & Growth Factor Reviews. 2021;57:73–84. http://dx.doi.org/10.1016/j.cytogfr.2020.06.003

9. Chao A, Tsai CL, Wei PC, Hsueh S, Chao AS, Wang CJ, Tsai CN, Lee YS, Wang TH, Lai CH. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett. 2010;291(1):99–107. https://doi.org/10.1016/j.canlet.2009.10.005

10. Zhang S, Shao J, Su F. Prognostic significance of STIP1 expression in human cancer: A meta-analysis. Clin Chim Acta. 2018;486:168–176. https://doi.org/10.1016/j.cca.2018.07.037

11. Carta F, Demuro PP, Zanini C, Santona A, Castiglia D, D’Atri S, Ascierto PA, Napolitano M, Cossu A, Tadolini B, Turrini F, Manca A, Sini MC, Palmieri G, Rozzo AC; Italian Melanoma Intergroup. Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res. 2005;15(4):235–244. https://doi.org/10.1097/00008390-200508000-00002

12. Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 2007;6(10):1798–1808. https://doi.org/10.1074/mcp.M600449-MCP200

13. Erlich RB, Kahn SA, Lima FR, Muras AG, Martins RA, Linden R, Chiarini LB, Martins VR, Moura Neto V. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia. 2007;55(16):16901698. https://doi.org/10.1002/glia.20579. PMID: 17886292.

14. Jing Y, Liang W, Liu J, Zhang L, Wei J, Zhu Y, Yang J, Ji K, Zhang Y, Huang Z. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis. Pathol Res Pract. 2019;215(11):152564. https://doi.org/10.1016/j.prp.2019.152564

15. Chao A, Liao MJ, Chen SH, Lee YS, Tsai CN, Lin CY, Tsai CL. JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells. Int J Mol Sci. 2022;23(5):2420. https://doi.org/10.3390/ijms23052420

16. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817–821. https://doi.org/10.1016/s0015-0282(97)81391-x

17. Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13. https://doi.org/10.1016/j.ijgo.2010.11.011

18. International working group of AAGL, ESGE, ESHRE and WES; Tomassetti C, Johnson NP, Petrozza J, Abrao MS, Einarsson JI, Horne AW, Lee TTM, Missmer S, Vermeulen N, Zondervan KT, Grimbizis G, De Wilde RL. An international terminology for endometriosis, 2021. J Minim Invasive Gynecol. 2021;28(11):1849–1859. https://doi.org/10.1016/j.jmig.2021.08.032

19. Yarmolinskaya MI, Shalina MA, Nagorneva SV. Modern approaches to classification of adenomyosis. Journal of obstetrics and women’s diseas‑ es. 2023;72(1):97–108 (In Russ.). http://dx.doi.org/10.17816/jowd121307

20. Qi S, Zhao X, Li M, Zhang X, Lu Z, Yang C, Zhang C, Zhang H, Zhang N. Aberrant expression of Notch1/numb/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis. Reprod Biol Endocrinol. 2015;13:96. https://doi.org/10.1186/s12958-015-0084-2

21. Huang TS, Chen YJ, Chou TY, Chen CY, Li HY, Huang BS, Tsai HW, Lan HY, Chang CH, Twu NF, Yen MS, Wang PH, Chao KC, Lee CC, Yang MH. Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells. J Cell Mol Med. 2014;18(7):1358–1371. https://doi.org/10.1111/jcmm.12300

22. Zhang S, Shao J, Su F. Prognostic significance of STIP1 expression in human cancer: A meta-analysis. Clin Chim Acta. 2018;486:168–176.